Market Tracker

05/06 2:46pm ET

Emergent BioSolutions Inc (NYSE:EBS)

37.57
BATS BZX Real-Time Price
As of 1:45pm ET
 -0.285 / -0.75%
Today’s Change
27.68
Today|||52-Week Range
40.96
-6.11%
Year-to-Date

Today’s Trading

Previous close37.85
Today’s open37.62
Day’s range37.40 - 38.80
Volume24,964
Average volume (3 months)427,822
Market cap$1.5B
Dividend yield--
Data as of 1:45pm ET, 05/06/2016

Growth & Valuation

Earnings growth (last year)+60.23%
Earnings growth (this year)+27.19%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)+16.14%
P/E ratio28.6
Price/Sales3.62
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+2.54+6.80%
HCMHutchison China Medi...+0.60+4.80%
IRWDIronwood Pharmaceuti...-0.10-0.99%
TXMDTherapeuticsMD Inc-0.15-1.89%
Data as of 2:43pm ET, 05/06/2016

Financials

Last reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$522.8M
Annual profit (last year)$62.9M
Net profit margin12.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts